Risk stratification and triage in the emergency department: Has this become 'suPAR' easy?

Journal of Internal Medicine

Volumn 272, Issue 3, 2012, Pages 243-246

  Koch, A ^a   Tacke, F ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE;

CHRONIC DISEASE; DISEASE MARKER; EDITORIAL; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; HUMAN; INTENSIVE CARE UNIT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

BACTERIAL INFECTIONS; FEMALE; HUMANS; MALE; SEPSIS; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84865540189     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2012.02568.x     Document Type: Editorial

References (17)

1. Challen K, Goodacre SW. Predictive scoring in non-trauma emergency patients: a scoping review. Emerg Med J 2011; 28: 827-37.
2. Thuno M, Macho B, Eugen-Olsen J. suPAR: the molecular crystal ball. Dis Markers 2009; 27: 157-72.
3. Koch A, Tacke F. Why high suPAR is not super-diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU. Crit Care 2011; 15: 1020.
4. Eugen-Olsen J. TsuPAR - a future risk marker. J Intern Med 2011; 270: 29-31.
5. Rabna P, Andersen A, Wejse C et al. Urine suPAR levels compared with plasma suPAR levels as predictors of post-consultation mortality risk among individuals assumed to be TB-negative: a prospective cohort study. Inflammation 2010; 33: 374-80.
6. Backes Y, van der Sluijs KF, Tuip de Boer AM et al. Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study. Crit Care 2011; 15: R270.
7. Tzanakaki G, Paparoupa M, Kyprianou M, Barbouni A, Eugen-Olsen J, Kourea-Kremastinou J. Elevated soluble urokinase receptor values in CSF, age and bacterial meningitis infection are independent and additive risk factors of fatal outcome. Eur J Clin Microbiol Infect Dis 2012; 31: 1157-62.
8. Eugen-Olsen J, Andersen O, Linneberg A et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med 2010; 268: 296-308.
9. Koch A, Voigt S, Kruschinski C et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 2011; 15: R63.
10. Uusitalo-Seppälä R, Huttunen R, Tarkka M et al. Soluble urokinase-type plasminogen activator receptor (suPAR) in emergency room patients with suspected infection: a prospective cohort study. J Intern Med 2012; doi:10.1111/j.1365-2796.2012.02569.x.
11. Kofoed K, Andersen O, Kronborg G et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 2007; 11: R38.
12. Savva A, Raftogiannis M, Baziaka F et al. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis. J Infect 2011; 63: 344-50.
13. Yilmaz G, Koksal I, Karahan SC, Mentese A. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome. Clin Biochem 2011; 44: 1227-30.
14. Donadello K, Scolletta S, Covajes C, Vincent JL. suPAR as a prognostic biomarker in sepsis. BMC Med 2012; 10: 2.
15. Zimmermann HW, Koch A, Seidler S, Trautwein C, Tacke F. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis. Liver Int 2011; 32: 500-9.
16. Wei C, El Hindi S, Li J et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011; 17: 952-60.
17. Kofoed K, Eugen-Olsen J, Petersen J, Larsen K, Andersen O. Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor. Eur J Clin Microbiol Infect Dis 2008; 27: 375-83.